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Summary box
 ► A cluster randomised controlled trial in Burkina Faso 
evaluating the impact of a mass media behaviour 
change campaign showed a highly significant im-
pact on child consultations for malaria (56% in-
crease in 1st year), diarrhoea (73%) and pneumonia 
(39%), but did not detect an effect on child mortality.
 ► The trial was not, and could not be, adequately pow-
ered to detect a reduction in child mortality of 10% 
or less, so a well-established modelling tool was 
used to estimate the effect of these intermediate 
outcomes on lives saved.
 ► Modelling was considered justified in the context of 
strong improvement in these important intermediate 
outcomes and good availability of the drugs needed 
to treat malaria, diarrhoea and pneumonia.
 ► Demand-side interventions are not a substitute for 
health system strengthening or other supply-side 
interventions, but treatment seeking is a neces-
sary precondition for any child to receive life-saving 
treatment.
Colbourn et al1 raise three interesting questions. 
(1) Whether, if a randomised controlled trial 
(RCT) fails to detect an effect on the primary 
outcome but shows a significant effect on an 
intermediate outcome, it is legitimate to model 
the effect? (2) Whether the modelling was 
performed correctly? and (3) Whether it is 
meaningful to focus on demand-side factors in 
isolation?
(1) We would argue that it is legitimate to use 
a model to evaluate an effect that the RCT was 
not, and could not be, powered to detect, where 
there is strong evidence of an impact on an 
important intermediate outcome, provided the 
limitations of such an exercise are appropriately 
acknowledged.
Measuring the effect of media campaigns is 
challenging. Very few countries have the very 
low national radio and television penetration 
and high local radio listenership that make it 
possible to evaluate a radio campaign through 
a cluster randomised trial.2 Even in those few 
countries where media configurations are suit-
able, the power to detect important changes 
in mortality is constrained by the mortality rate 
and the number of clusters that can be achieved 
(14 in the case of Burkina Faso).
When we began our study in 2011, we designed 
our trial to have 80% power to detect a mortality 
reduction of 20% but just 30% and 8% power 
to detect reductions of 10% and 5% respec-
tively. Due to the constraints outlined above, it 
was impossible to power the study to detect small 
reductions. Rapidly falling mortality during the 
study period (from 115.5/1000 to 76.5/1000 in 
the control arm) will have further reduced our 
study’s power. Given the lack of power to detect a 
reduction in mortality in the range of 5%–10%, 
it is important to remember that ‘absence of 
evidence is not evidence of absence’. Colbourn 
et al attach considerable importance to the 
point estimate, but our mortality estimates do 
not preclude anything from an important nega-
tive effect to an important positive effect.
More generally, it is also important not to 
overstate the certainty provided by survey-based 
methods which rely on mothers’ recall to esti-
mate child mortality trends in countries lacking 
fully functioning vital registration systems. 
Mortality surveys can be subject to uncertainties 
greater than the effect sizes we were attempting 
to measure.
We did observe important changes in 
behaviour, using health centre records of 
over 600 000 consultations: a 56% increase in 
parents taking their children for malaria treat-
ment (p<0.001) in the first year and similar 
results for pneumonia (39%, p<0.001) and diar-
rhoea (73%, p<0.001).3 Given the survey’s lack 
of power to detect smaller changes in mortality, 
we used LiST to estimate the effect of increased 
care seeking on mortality. LiST is a widely used 
and accepted tool for estimating the likely 
mortality impact of different interventions. 
The cost-effectiveness calculations simply follow 
from the mortality reductions predicted by 
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LiST. The stated conclusion of our study was that ‘large-scale 
mass media campaigns encouraging prompt care seeking 
for children can be highly cost-effective in improving child 
survival.’4
(2) Colbourn et al raise four methodological concerns:
1. With regard to the ‘compression’ of the consultation 
counts, we adopted this approach in the context of mul-
tiple diagnoses during one consultation to avoid dou-
ble-counting deaths averted. The method was applied 
consistently and correctly to all three diagnoses.
2. For pneumonia treatment rates, we used the LiST de-
fault approach which is to use the consultation rate 
with no adjustment for treatment rate. LiST takes this 
approach based on evidence that pneumonia treatment 
rates estimated from survey data are not valid.5 6 This has 
limited effect on the projections because the assump-
tion applies to both the intervention and control groups 
(and because pneumonia represents a small percentage 
of the total lives saved). If we reduce the percentage of 
pneumonia cases treated from 52.7% to 44.8%, corre-
sponding to reduced treatment arising from amoxicillin 
and cotrimoxazole stockouts, 7 the effect on the project-
ed lives saved is small (from 7.1% to 6.9%).
3. The reasons for the relative decrease in consultations for 
‘other diagnoses’ in the trial’s intervention arm are un-
clear; however, it is worth noting that ‘other’ diagnoses 
actually increase in both arms. This could possibly be due 
to strengthening in the implementation of Integrated 
Management of Childhood Illness. However, because 
the ‘other’ consultation data were aggregated, we lacked 
the data to investigate which diagnoses contributed to 
these trends.
4. Colbourn et al are correct that the lower bound of the re-
ported lives saved for 2014, reported in table 1 in Murray 
et al 3 should be negative. The correct lower bounds for 
2013 and 2014 should be 35 and −14, respectively, with 
the overall lower bound being 798 and not 1110. This 
error affects only the lower bounds and not the over-
all percentage reduction in mortality which remains at 
7.1%.
(3) While Colbourn et al are, of course, correct that health 
systems are complex and that treatment seeking is worth-
less without available treatments and a functioning health 
system, the reverse argument is also true: if sick children 
are not brought for treatment, no health system is going to 
be able to save their lives. Very few would argue that appro-
priate treatment with effective antimalarials, antibiotics and 
oral rehydration salt (ORS) cannot save lives, and WHO and 
UNICEF have recommended prompt care seeking for these 
conditions for many years. 8 9 Care seeking is an important 
intermediate outcome and a precondition for everything 
that follows in the causal pathway leading to deaths averted. 
There are therefore strong grounds for believing that, if the 
health system is functioning reasonably well, improvements 
in care seeking can save lives.
In Burkina Faso, the evidence suggests that the health 
system was functioning reasonably well. As we note in the 
article, the WHO 2014 Service and Availability Readiness 
Assessment report indicates good availability of key life-
saving treatments in primary health facilities in Burkina 
Faso: 91% for malaria treatment, 82% for ORS sachets and 
83%–85% for antibiotics.7
In conclusion, we consider that it is legitimate to use a 
well-established modelling tool to estimate a health impact 
when there is strong evidence of an impact on an important 
intermediate outcome but little or no power to detect an 
impact on the health outcome itself. The limitations of such 
an exercise, of course, must be appropriately acknowledged.
However, we are in complete agreement that demand-
side interventions are not a substitute for health systems 
strengthening or other supply-side interventions. Our study 
simply shows that demand-side interventions should not be 
confined to the periphery of public health and have the 
potential to save lives when used as part of a functioning 
health system.
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